KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Dec 04, 2024 - 1:45PM >>  ABB India 7646.8  [ 1.43% ]  ACC 2246.4  [ -1.97% ]  Ambuja Cements 562  [ -0.83% ]  Asian Paints Ltd. 2461  [ -0.32% ]  Axis Bank Ltd. 1158.1  [ -0.17% ]  Bajaj Auto 9028.05  [ -1.45% ]  Bank of Baroda 255.8  [ 0.51% ]  Bharti Airtel 1589.1  [ -1.89% ]  Bharat Heavy Ele 251  [ -0.53% ]  Bharat Petroleum 294.8  [ 0.22% ]  Britannia Ind. 4896.2  [ -0.27% ]  Cipla 1507.15  [ -1.78% ]  Coal India 419.65  [ -0.57% ]  Colgate Palm. 2858  [ -1.32% ]  Dabur India 521.2  [ -0.31% ]  DLF Ltd. 842.8  [ -0.48% ]  Dr. Reddy's Labs 1213.9  [ -0.91% ]  GAIL (India) 204.4  [ 2.20% ]  Grasim Inds. 2704.3  [ -0.36% ]  HCL Technologies 1884  [ -0.27% ]  HDFC 2729.95  [ -0.62% ]  HDFC Bank 1855  [ 1.54% ]  Hero MotoCorp 4633  [ -1.37% ]  Hindustan Unilever L 2481.5  [ 0.01% ]  Hindalco Indus. 661.25  [ -0.88% ]  ICICI Bank 1310.35  [ 0.23% ]  IDFC L 108  [ -1.77% ]  Indian Hotels Co 811.25  [ 0.61% ]  IndusInd Bank 994.2  [ -0.42% ]  Infosys L 1885  [ -0.34% ]  ITC Ltd. 471.5  [ -0.17% ]  Jindal St & Pwr 922.75  [ -0.29% ]  Kotak Mahindra Bank 1755.75  [ 0.36% ]  L&T 3787  [ 0.10% ]  Lupin Ltd. 2083.7  [ 0.11% ]  Mahi. & Mahi 3024  [ -0.07% ]  Maruti Suzuki India 11158.45  [ -1.06% ]  MTNL 49.4  [ 0.53% ]  Nestle India 2250.15  [ -0.46% ]  NIIT Ltd. 221  [ -0.50% ]  NMDC Ltd. 233.15  [ -1.02% ]  NTPC 370.95  [ 0.94% ]  ONGC 261.8  [ -0.17% ]  Punj. NationlBak 108.4  [ 0.42% ]  Power Grid Corpo 323.9  [ -1.77% ]  Reliance Inds. 1309  [ -1.08% ]  SBI 853  [ -0.11% ]  Vedanta 465.05  [ -0.70% ]  Shipping Corpn. 237.35  [ -0.15% ]  Sun Pharma. 1788.45  [ -0.56% ]  Tata Chemicals 1127  [ -0.80% ]  Tata Consumer Produc 952.9  [ -0.13% ]  Tata Motors 786.3  [ -1.85% ]  Tata Steel 144.7  [ -1.26% ]  Tata Power Co. 425.15  [ -0.85% ]  Tata Consultancy 4347.55  [ 1.07% ]  Tech Mahindra 1750  [ 0.03% ]  UltraTech Cement 11812.95  [ -0.31% ]  United Spirits 1525.7  [ -1.09% ]  Wipro 293.25  [ 0.53% ]  Zee Entertainment En 137.7  [ -0.29% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    AARTI DRUGS LTD.

    04 December 2024 | 01:34

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE767A01016 BSE Code / NSE Code 524348 / AARTIDRUGS Book Value (Rs.) 140.34 Face Value 10.00
    Bookclosure 05/09/2024 52Week High 635 EPS 18.78 P/E 24.54
    Market Cap. 4207.09 Cr. 52Week Low 431 P/BV / Div Yield (%) 3.28 / 0.22 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    Aarti Drugs Limited was incorporated on 28th September, 1984 as a Private Limited Company. It was converted into a Public Limited Company on 1st July, 1992.

    The Company is presently engaged in the manufacture of MNI(300 TPA), MTZ (96 TPA), TNZ (84 TPA), DMZ (90 TPA) and Isoniazid (INH) (96 TPA). The Company started its commercial production is March 1987 at G.I.D.C. Industrial Estate, Sarigam, Dist. Valsad, Gujarat. This project was put up with financial assistance from Gujarat State Finance Corporation (GSFC) and Gujarat Industrial Investment Corporation (GIIC).

    The Company now proposes to expand the capacities for the above products, except INH and also proposes to set up a new plant for the manufacture of Glyoxal and Ammonium Sulphate. The Company has been consistently making profits and has maintained an unbroken dividend record since the year 1990-91.

    The Company is a part of the Alchemie Group of Companies. The Company is promoted by Mr. Chandrakant V.Gogri, Mr.Rajendra V.Gogri and Mr. Shantilal T. Shah. Mr. P.M. Patil and Mr. S. P. Nachane joined the Group in 1981. The Alchemie Group is a professionally managed, multi-product, multilocation Group comprising 24 manufacturing units with a total turnover of over Rs.100 crores for the year 1991-92. The products of the Group, exceeding 40, range from industrial chemicals and dye intermediates to bulk drugs and fine chemicals. The Group's customer list includes most of the leading chemical companies in the country. The Group's turnover and profits have increased five-fold in the last 5 years. It also recorded an export turnover of more than Rs. 30 crores in the year 1991-92. The Group units export products mainly to the general currency areas such as USA, UK, Switzerland and Germany.

    2000 - The Company proposed to acquire 15,31,000 No. of equity shares of Alchemie Organics Ltd 33.44 per cent of the total paid-up capital of AOL held by the other promoters.

    2002-Gauri Balankhe appointed as Compliance Officer of Aarti Drugs.

    2004

    -Aarti Drugs Ltd. has informed that the Company has changed its Registrar and Share Transfer Agent and Depository interface for Handling Depository related operations by appointing M/s Sharepro Services in place of M/s R & D Consultants Ltd w.e.f. January 16, 2004 subject to completion of necessary formalities as maybe prescribed in this regard. The address and telephone number of M/s Sharepro Services for all investors related services are as under: 1. M/s Sharepro Services, Unit : Aarti Drugs Ltd; 912, Raheja Centre, Free Press Journal Road, Nariman Point, Mumbai 400 021, Tel nos : 22881569, 22884527. 2. M/s Sharepro Services, Unit : Aarti Drugs Ltd; 912, Satam Estate, 3rd Floor, Above Bank of Baroda, Chakla, Andheri (East), Mumbai 400 099, Tel nos : 28215168, 28319828; Fax nos : 28375646.

    -Aarti bags European certification for three drugs

    -Delist from Ahmedabad Stock Exchange (ASE) with effect from October 15, 2004.

    2006

    -Aarti Drugs enters into JV with API Manufacturing Chinese Company

    - Aarti Drugs Ltd. has informed that Mr. Prakash Khedekar, Company Secretary & Compliance Officer of the Company has resigned from the position of Company Secretary & Compliance Officer with effect from October 31, 2006. Further, Mrs. Mona Patel, possessing requisite qualifications, has been appointed as Company Secretary & Compliance Officer of the Company with effect from November 01, 2006.

    2009

    - Aarti Drugs Ltd has has appointed Shri Krishnacharya Govindacharya Akamanchi & Prof. Sudhir Prakash B. Sawant as Independent Directors of the Company.

    2010

    -Aarti Drugs has recommended dividend of Rs. 5/- (50%) per share

    2011

    -Mr. Sunny D. Pagare, has been appointed as Company Secretary & Compliance Officer of the Company

    -Aarti Drugs has recommended Final Dividend of Rs. 2.5 /-per share (25%)

    2012

    -Mr. Adhish P. Patil, has been appointed as Chief Financial Officer of the Company

    -Aarti Drugs has declared Final dividend Rs. 3.00 (30%) per share

    2013 -Aarti Drugs has recommended a Final Dividend of Rs. 4/- per share on Equity Shares of Rs. 10/- each.

    2014 -Aarti Drugs has commenced the new R&D center at MIDC Tarapur. -Aarti Drugs has recommended a Final dividend @ Rs. 5.50 ps. (55%) per share.

    2015 -Aarti Drugs Ltd has will participate at 'Centrum Pharma Day' Investor Conference -The Company has allotted the Bonus Shares to its shareholders in the Ratio of 1:1.

    2020 -The Company has issued Bonus Shares in the Ratio of 3:1.

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.